Origin and fluxes of atmospheric REE entering an ombrotrophic peat bog in Black Forest (SW Germany): Evidence from snow, lichens and mosses

The fate of the Rare Earth Elements (REE) were investigated in different types of archives of atmospheric deposition in the Black Forest, Southern Germany: (1) a 70 cm snow pack collected on the domed part of a raised bog and representing 2 months of snow accumulation, (2) a snow sample collected close to the road about 500 m from the peat bog, (3) two species of lichens and (4) a peat profile representing 400 years of peat accumulation as well as a “preanthropogenic” sample and the living moss layer from the top of the core. REE concentrations in peat are significantly correlated to Ti which is a lithogenic conservative element suggesting that REE are immobile in peat bog environments. Snow, lichens and peat samples show similar PAAS (Post Archean Australian Shale) normalized REE distributions suggesting that the complete atmospheric REE signal is preserved in the peat profile. However, the annual flux of REE accumulated by the peat is ca. 10 times greater than that of the bulk winter flux of REE. This difference probably indicates that the REE concentrations in the snowpack are not representative of the average REE flux over the whole year. Despite the pronounced geological differences between this site (granite host-rock) and a previously studied peat bog in Switzerland (limestone host-rock) similar REE distribution patterns and accumulation rates were found at both sites. Given that both sites confirm an Upper Continental Crust signature, the data suggests both sites are influenced by regional and not local, soil-derived lithogenic aerosols

Recent atmospheric Pb deposition at a rural site in southern Germany assessed using a peat core and snowpack, and comparison with other archives

In a peat bog from Black Forest, Southern Germany, the rate of atmospheric Pb accumulation was quantified using a peat core dated by 210Pb and 14C. The most recent Pb accumulation rate (2.5 mg m−2 y−1) is similar to that obtained from a snowpack on the bog surface, which was sampled during the winter 2002 (1 to 4 mg m−2 y−1). The Pb accumulation rates recorded by the peat during the last 25 yr are also in agreement with published values of direct atmospheric fluxes in Black Forest. These values are 50 to 200 times greater than the “natural” average background rate of atmospheric Pb accumulation (20 μg m−2 y−1) obtained using peat samples from the same bog dating from 3300 to 1300 cal. yr B.C. The isotopic composition of Pb was measured in both the modern and ancient peat samples as well as in the snow samples, and clearly shows that recent inputs are dominated by anthropogenic Pb. The chronology and isotopic composition of atmospheric Pb accumulation recorded by the peat from the Black Forest is similar to the chronologies reported earlier using peat cores from various peat bogs as well as herbarium samples of Sphagnum and point to a common Pb source to the region for the past 150 years. In contrast, Pb contamination occurring before 1850 in southwestern Germany, differs from the record published for Switzerland mainly due to the mining activity in Black Forest. Taken together, the results show that peat cores from ombrotrophic bogs can yield accurate records of atmospheric Pb deposition, provided that the cores are carefully collected, handled, prepared, and analysed using appropriate methods

Carbonate precipitation, U-series dating and U-isotopic variations in a Holocene travertine platform at Bad Langensalza - Thuringia Basin, Germany

Travertine and calcareous tufa deposits, are important archives for Quaternary continental climate and archaeology. Here we present a comprehensive study on Holocene travertine deposition in the Thuringia basin based on a detailed survey of U-series measurements and dating that demonstrates rapid accumulation of carbonate during the early Holocene until 8000 years (up to 8 mm yr–1) followed by significant change in travertine accumulation that ended around 5800 years BP at the investigated site. We further demonstrate that systematic changes of the U-isotopic composition through time occur in agreement with major changes in travertine accumulation and texture, which are likely to reflect changes of spring water U-isotopic composition rather than U-series system opening or contamination with non-carbonate particles.Les travertins et les tufs calcaires constituent des archives importantes pour les études sur le climat continental quaternaire et l’Archéologie. Nous présentons l’étude de la formation d’un travertin holocène du bassin de Thuringe, basée sur un exposé détaillé des données uranium-thorium et des âges U-Th obtenus, qui démontrent une accumulation rapide du carbonate pendant le début de l’Holocène jusque vers 8000 ans (jusqu’à 8 mm par an) suivie par un changement significatif dans le rythme d’accumulation du travertin qui s’achève vers 5800 ans BP sur le site étudié. Nous démontrons ensuite que les changements systématiques dans la composition isotopique de l’uranium au cours du temps sont en accord avec les variations majeures de texture et d’accumulation du travertin et reflètent les changements de composition isotopique de l’uranium des eaux de source plutôt qu’une ouverture du système des séries de l’uranium voire une contamination par des particules non carbonatées

Understanding the degradation of methylenediammonium and its role in phase-stabilizing formamidinium lead triiodide

Formamidinium lead triiodide (FAPbI3) is the leading candidate for single-junction metal–halide perovskite photovoltaics, despite the metastability of this phase. To enhance its ambient-phase stability and produce world-record photovoltaic efficiencies, methylenediammonium dichloride (MDACl2) has been used as an additive in FAPbI3. MDA2+ has been reported as incorporated into the perovskite lattice alongside Cl–. However, the precise function and role of MDA2+ remain uncertain. Here, we grow FAPbI3 single crystals from a solution containing MDACl2 (FAPbI3-M). We demonstrate that FAPbI3-M crystals are stable against transformation to the photoinactive δ-phase for more than one year under ambient conditions. Critically, we reveal that MDA2+ is not the direct cause of the enhanced material stability. Instead, MDA2+ degrades rapidly to produce ammonium and methaniminium, which subsequently oligomerizes to yield hexamethylenetetramine (HMTA). FAPbI3 crystals grown from a solution containing HMTA (FAPbI3-H) replicate the enhanced α-phase stability of FAPbI3-M. However, we further determine that HMTA is unstable in the perovskite precursor solution, where reaction with FA+ is possible, leading instead to the formation of tetrahydrotriazinium (THTZ-H+). By a combination of liquid- and solid-state NMR techniques, we show that THTZ-H+ is selectively incorporated into the bulk of both FAPbI3-M and FAPbI3-H at ∼0.5 mol % and infer that this addition is responsible for the improved α-phase stability

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

Background: Glucagon-like peptide 1 receptor agonists differ in chemical structure, duration of action, and in their effects on clinical outcomes. The cardiovascular effects of once-weekly albiglutide in type 2 diabetes are unknown. We aimed to determine the safety and efficacy of albiglutide in preventing cardiovascular death, myocardial infarction, or stroke. Methods: We did a double-blind, randomised, placebo-controlled trial in 610 sites across 28 countries. We randomly assigned patients aged 40 years and older with type 2 diabetes and cardiovascular disease (at a 1:1 ratio) to groups that either received a subcutaneous injection of albiglutide (30–50 mg, based on glycaemic response and tolerability) or of a matched volume of placebo once a week, in addition to their standard care. Investigators used an interactive voice or web response system to obtain treatment assignment, and patients and all study investigators were masked to their treatment allocation. We hypothesised that albiglutide would be non-inferior to placebo for the primary outcome of the first occurrence of cardiovascular death, myocardial infarction, or stroke, which was assessed in the intention-to-treat population. If non-inferiority was confirmed by an upper limit of the 95% CI for a hazard ratio of less than 1·30, closed testing for superiority was prespecified. This study is registered with ClinicalTrials.gov, number NCT02465515. Findings: Patients were screened between July 1, 2015, and Nov 24, 2016. 10 793 patients were screened and 9463 participants were enrolled and randomly assigned to groups: 4731 patients were assigned to receive albiglutide and 4732 patients to receive placebo. On Nov 8, 2017, it was determined that 611 primary endpoints and a median follow-up of at least 1·5 years had accrued, and participants returned for a final visit and discontinuation from study treatment; the last patient visit was on March 12, 2018. These 9463 patients, the intention-to-treat population, were evaluated for a median duration of 1·6 years and were assessed for the primary outcome. The primary composite outcome occurred in 338 (7%) of 4731 patients at an incidence rate of 4·6 events per 100 person-years in the albiglutide group and in 428 (9%) of 4732 patients at an incidence rate of 5·9 events per 100 person-years in the placebo group (hazard ratio 0·78, 95% CI 0·68–0·90), which indicated that albiglutide was superior to placebo (p<0·0001 for non-inferiority; p=0·0006 for superiority). The incidence of acute pancreatitis (ten patients in the albiglutide group and seven patients in the placebo group), pancreatic cancer (six patients in the albiglutide group and five patients in the placebo group), medullary thyroid carcinoma (zero patients in both groups), and other serious adverse events did not differ between the two groups. There were three (<1%) deaths in the placebo group that were assessed by investigators, who were masked to study drug assignment, to be treatment-related and two (<1%) deaths in the albiglutide group. Interpretation: In patients with type 2 diabetes and cardiovascular disease, albiglutide was superior to placebo with respect to major adverse cardiovascular events. Evidence-based glucagon-like peptide 1 receptor agonists should therefore be considered as part of a comprehensive strategy to reduce the risk of cardiovascular events in patients with type 2 diabetes. Funding: GlaxoSmithKline

Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches

Extracellular vesicles (EVs), through their complex cargo, can reflect the state of their cell of origin and change the functions and phenotypes of other cells. These features indicate strong biomarker and therapeutic potential and have generated broad interest, as evidenced by the steady year-on-year increase in the numbers of scientific publications about EVs. Important advances have been made in EV metrology and in understanding and applying EV biology. However, hurdles remain to realising the potential of EVs in domains ranging from basic biology to clinical applications due to challenges in EV nomenclature, separation from non-vesicular extracellular particles, characterisation and functional studies. To address the challenges and opportunities in this rapidly evolving field, the International Society for Extracellular Vesicles (ISEV) updates its 'Minimal Information for Studies of Extracellular Vesicles', which was first published in 2014 and then in 2018 as MISEV2014 and MISEV2018, respectively. The goal of the current document, MISEV2023, is to provide researchers with an updated snapshot of available approaches and their advantages and limitations for production, separation and characterisation of EVs from multiple sources, including cell culture, body fluids and solid tissues. In addition to presenting the latest state of the art in basic principles of EV research, this document also covers advanced techniques and approaches that are currently expanding the boundaries of the field. MISEV2023 also includes new sections on EV release and uptake and a brief discussion of in vivo approaches to study EVs. Compiling feedback from ISEV expert task forces and more than 1000 researchers, this document conveys the current state of EV research to facilitate robust scientific discoveries and move the field forward even more rapidly

Im Archiv der Erde. Wie Wissenschaftler die Zeichen der Zeit lesen

100 Jahre – so lange lebt kaum ein Mensch, in der Astronomie jedoch ist diese Zeitspanne fast bedeutungslos: Nicht einen einzigen vollständigen Umlauf um die Sonne kann der Planet Neptun in einem Jahrhundert zurücklegen; und unser Sonnensystem vollzieht in dieser Zeit weniger als ein Millionstel seiner Bahn um das Zentrum der Milchstraße. Wenn Menschen über kosmische Objekte nachdenken, müssen sie sich auf Zeiträume von Jahrmillionen und Jahrmilliarden einlassen. Die Begriffe Jung und Alt erhalten dabei gänzlich andere Dimensionen.Menschen sind neugierig: Wo kommen wir her, wie haben wir uns entwickelt? Viele wissenschaftliche Disziplinen suchen Antworten auf diese Fragen – sie alle sind auf ein genaues Zeitgerüst für die schriftlose Vorgeschichte angewiesen. Die Begriffe ALT und JUNG umfassen dabei Episoden von Tausenden bis hin zu Millionen Jahren und nicht, wie in unserem Sprachgebrauch üblich, die Zeitspanne des menschlichen Lebens. Um in diesen Dimensionen absolutes Alter zu bestimmen, hat die Geochronologie Methoden hervorgebracht, die auf der Analyse urzeitlicher Materialien wie Gesteinen, Mineralen, Hölzern oder Skelettresten beruhen. Damit hat sie das Verständnis der Erdgeschichte revolutioniert und unser modernes Weltbild enorm beeinflusst. Wissenschaftler der Universität Heidelberg haben entscheidend zu der Entwicklung dieser Methoden beigetragen